Should settle a few nerves and apply some pressure to the corporate pharma world.
Ann: Opthea Completes Enrollment in Phase 3 Clinical Program, page-2
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.010(2.67%) |
Mkt cap ! $492.4M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 40.0¢ | 37.5¢ | $1.163M | 3.000M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1406 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 16684 | 2 |
View Market Depth
| Last trade - 15.59pm 18/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |